COVID-19

The emergence of COVID-19-induced parkinsonism 2:48
The emergence of COVID-19-induced parkinsonism
Angelo Antonini • 29 Mar 2022
Increasing mobility in patients with Parkinson’s disease during COVID-19 2:58
Increasing mobility in patients with Parkinson’s disease during COVID-19
Angelo Antonini • 29 Mar 2022
The importance of studying long-term COVID-19 neurological symptoms 2:12
The importance of studying long-term COVID-19 neurological symptoms
Giulio Pasinetti • 18 Mar 2022
Evaluating the reduction in stroke admissions during COVID-19 4:37
Evaluating the reduction in stroke admissions during COVID-19
Ashfaq Shuaib • 24 Mar 2022
Telemedicine in headache care: a cohort study 3:24
Telemedicine in headache care: a cohort study
Chia-Chun Chiang • 3 Apr 2022
Cerebral venous thrombosis in the setting of COVID-19 vaccination 3:50
Cerebral venous thrombosis in the setting of COVID-19 vaccination
Diana Aguiar de Sousa • 29 Apr 2022
COVID-19 and narcolepsy: the same incident as swine flu? 0:53
COVID-19 and narcolepsy: the same incident as swine flu?
Mink Schinkelshoek • 15 Mar 2022
Elucidating the pathology of post COVID-19 headaches 3:28
Elucidating the pathology of post COVID-19 headaches
Dimos-Dimitrios Mitsikostas • 22 Mar 2022
The effect of the COVID-19 pandemic on neurology research 2:21
The effect of the COVID-19 pandemic on neurology research
Nina Schor • 4 Apr 2022
Functional neurological disorders surge during the COVID-19 pandemic 1:52
Functional neurological disorders surge during the COVID-19 pandemic
Davide Martino • 3 Apr 2022
Prognostic value of circulating NfL for COVID-19 mortality 9:26
Prognostic value of circulating NfL for COVID-19 mortality
Ruturaj Masvekar • 11 Mar 2022
Meta-analyses in sleep medicine 2:49
Meta-analyses in sleep medicine
Gabriel Pires • 14 Mar 2022
The autonomic symptoms and manifestations of post-acute COVID syndrome 2:39
The autonomic symptoms and manifestations of post-acute COVID syndrome
Mitchell Miglis • 3 Mar 2022
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with MS treated with DMTs 3:15
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with MS treated with DMTs
Virginia Meca-Lallana • 28 Feb 2022
COVID-19 outcomes in patients with relapsing MS receiving cladribine 2:22
COVID-19 outcomes in patients with relapsing MS receiving cladribine
Gavin Giovannoni • 1 Mar 2022
Characterizing real-world outcomes among COVID-19 vaccinated patients with MS 2:07
Characterizing real-world outcomes among COVID-19 vaccinated patients with MS
Namita Tundia • 25 Feb 2022
The content of VJNeurology is intended for healthcare professionals